https://clinicaltrials.gov/ct2/show/NCT03245385?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F09%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
DESCRIPTION:
Condition: Atopic Dermatitis
Intervention: Drug: Treatment with Halobetasol propionate 0.05% topical spray
Sponsors: Sun Pharmaceutical Industries Limited; Novum Pharmaceutical Research Services
Suspended
CLINICALTRIALS.GOV IDENTIFIER:
NCT03245385
FIRST POSTED:
Thu, 10 Aug 2017 12:00:00 EDT
LAST UPDATE POSTED:
09/23/19 07:49AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03245385?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F09%2F2019&lupd_d=14&sort=nwst
